- Spread to 17 nations from India: Scientists
By Pradeep Kumar
NAHARLAGUN, May 15: The initial results of genomic sequencing of the sample of COVID-19 shows that the Indian strain of corona virus B.1.617.2 variant has been detected in Arunachal Pradesh recently, according to results of DNA sequencing of COVID-19 samples sent by RTPCR lab TRIHMS to Dibrugarh-based ICMR-RMRC in Assam.
Disclosing this in a release on Saturday, Tomo Riba Institute of Health Medical Sdience PRO-cum-media cell in-charge Dr. Jego Ori said: “The only way to escape COVID-19 infection now is to strictly follow the prescribed SOPs and appropriate behavior”.
A ferocious second COVID-19 wave has devastated India and caught authorities unaware as several coronavirus variants, including B.1.617.2, have been circulating in the country which also surfaced in Arunachaal.
Scientist Gayathri Vaidyanathan has claimed that new COVID variants, including B.1.617, have been linked to India’s surge in infections. Researchers are hurrying to determine how much threats they pose.
On May 7, the United Kingdom Govt declared the B.1.617.2 subtype a variant of concern for the country whose infections had risen from 202 to 520 in a week.
On May 10, World Health Organization (WHO) designated B.1.617 a ‘variant of concern’. Variants are classified in this way when there is evidence that they spread more rapidly, cause more severe disease or evade previously acquired immunity better than do circulating versions of the virus. This ‘Indian Strain’ of COVID is found in 17 countries, WHO had said in April last.
Several other variants of concern have had a significant impact globally. These include B.1.351, which was identified in South Africa in late 2020; studies suggesting that the University of Oxford–AstraZeneca jab is less effective against that variant led to the nation suspending its roll-out. Similarly, the P.1 variant, which is able to evade some immunity, contributed to a major second wave in Brazil early this year. And the highly transmissible B.1.1.7 strain emerged in the United Kingdom in late 2020 and led to a surge of cases there and elsewhere.
Indian scientists first detected B.1.617 in a few samples in October last. INSACOG ramped up surveillance in late January in response to a rising number of variants, and scientists noticed that B.1.617 was on the rise in Maharashtra. By mid-February, it accounted for 60% of cases there, said Pune-based National Institute of Virology (NIV) director Priya Abraham. Since then, multiple sub-lineages have emerged.
In a detailed genomic and structural analysis of B.1.617 published as a preprint on May 3, NIV scientists identified eight mutations in the virus’s spike protein, through which it gains entry to cells. Two of them look similar to mutations that have allowed other variants of concern to become more transmissible, and a third resembles a mutation that might have allowed P.1 to partially evade immunity.
Two weeks ago, it looked as if multiple variants were behind a series of surges in India. Genomic data indicated that B.1.1.7, first identified in the United Kingdom, was dominant in Delhi and the state of Punjab, and a new variant dubbed B.1.618 was present in West Bengal. B.1.617 was dominant in Maharashtra.
But since then, B.1.617 has overtaken B.1.618 in West Bengal, has become the leading variant in many states, and is increasing rapidly in Delhi. “In some states, the surge can be tied to 617,” New Delhi-based National Centre for Disease Control director Sujeet Singh told journalists on May 5.
In just a few weeks, the B.1.617 variant has become the dominant strain across India and has spread to about 40 nations, including the United Kingdom, Fiji and Singapore.
Some say this could indicate that the variant is highly transmissible. “Its prevalence has increased over other variants in much of India, suggesting that it has better ‘fitness’ over those variants,” says Shahid Jameel, a virologist at Ashoka University in Sonipat who chairs the scientific advisory group of the Indian SARS-CoV-2 Genome Sequencing Consortia (INSACOG).
Ravindra Gupta, a virologist of University of Cambridge, UK, agrees that it is “highly likely to be more transmissible.”
Researchers want to know if this variant and others might be driving the second wave and what kind of danger they pose globally. (With agency inputs)
